Tag Archives: Zurampic

April, 2016

• 27 April

  AstraZeneca Sells Ironwood US Rights to its Gout Drug Zurampic

  

  26 April 2016 AstraZeneca today announced that it has entered into a licensing agreement with Ironwood Pharmaceuticals for the exclusive US rights to Zurampic® (lesinurad). Zurampic was approved by the US Food and Drug Administration (FDA) in December 2015, in combination with a xanthine oxidase inhibitor (XOI), for the treatment …

  Share

  • Facebook
  • Twitter
  • LinkedIn

December, 2015

• 28 December

  AstraZeneca’s Zurampic Receives FDA Approval for Patients with Gout

  

  22 December 2015 AstraZeneca today announced that the US Food and Drug Administration (FDA) has approved ZURAMPIC® (lesinurad) 200mg tablets in combination with a xanthine oxidase inhibitor (XOI) for the treatment of hyperuricemia associated with gout in patients who have not achieved target serum uric acid (sUA) levels with an …

  Share

  • Facebook
  • Twitter
  • LinkedIn